Docoh
Loading...

ARE Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc. an S&P 500® urban office real estate investment trust, is the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life science, technology and agtech campuses in AAA innovation cluster locations. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland and Research Triangle.

Company profile

Ticker
ARE
Exchange
Website
CEO
Peter M. Moglia / Stephen A. Richardson
Employees
Incorporated
Location
Fiscal year end
Former names
ALEXANDRIA REAL ESTATE EQUITIES INC
SEC CIK
IRS number
954502084

ARE stock data

(
)

Press releases

Pro users get this 30m faster
Alexandria Real Estate Equities, Inc., at the Vanguard of Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand from the Life Science Industry, Reports: 2Q21 and 1H21 Net Income per Share - Diluted of $2.61 and $2.74, respectively; 2Q21 and 1H21 FFO per Share - Diluted, As Adjusted, of $1.93 and $3.84, respectively
26 Jul 21
PASADENA, Calif., July 26, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the second quarter ended June 30, 2021. Key highlights Operating
Alexandria Real Estate Equities, Inc. Releases 2020 ESG Report Highlighting Its Pioneering Sustainability and Social Impact Leadership
29 Jun 21
PASADENA, Calif., June 29, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on
Alexandria Real Estate Equities, Inc. Announces Underwriters' Exercise And Closing Of Option To Purchase Additional 1,050,000 Shares Of Common Stock
22 Jun 21
PASADENA, Calif., June 22, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE:ARE) today announced that the underwriters of its previously announced
Alexandria Real Estate Equities, Inc. Announces Closing of Public Offering of 7,000,000 Shares of Common Stock
17 Jun 21
Alexandria Real Estate Equities, Inc. Announces Pricing Of Upsized Public Offering Of 7,000,000 Shares Of Common Stock
14 Jun 21

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

26 Jul 21
2 Aug 21
31 Dec 21
Quarter (USD)
Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 357.57M 357.57M 357.57M 357.57M 357.57M 357.57M
Cash burn (monthly) 58.94M (positive/no burn) 125.6M 122.42M (positive/no burn) (positive/no burn)
Cash used (since last report) 65.79M n/a 140.19M 136.64M n/a n/a
Cash remaining 291.78M n/a 217.38M 220.94M n/a n/a
Runway (months of cash) 5.0 n/a 1.7 1.8 n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
29 Jul 21 Marcus Joel S Common Stock Sell Dispose S No No 200 15,000 3M 314,597
28 Jul 21 Marcus Joel S Common Stock Sell Dispose S No No 200.02 5,000 1M 329,597
28 Jul 21 Cunningham John H Common Stock Sell Dispose S No No 198.75 8,000 1.59M 45,084
28 Jul 21 Binda Marc E Common Stock Sell Dispose S No No 200 5,230 1.05M 45,822
15 Jul 21 Cain James P Common Stock Grant Aquire A No No 0 16 0 4,539
15 Jul 21 Hash Steve Common Stock Grant Aquire A No No 0 39 0 14,337

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

86.8% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 539 528 +2.1%
Opened positions 73 59 +23.7%
Closed positions 62 69 -10.1%
Increased positions 249 219 +13.7%
Reduced positions 154 176 -12.5%
13F shares
Current Prev Q Change
Total value 24.33B 23.76B +2.4%
Total shares 128M 133.32M -4.0%
Total puts 191.6K 54.2K +253.5%
Total calls 104K 107.4K -3.2%
Total put/call ratio 1.8 0.5 +265.1%
Largest owners
Shares Value Change
Vanguard 21.15M $3.48B +4.3%
BLK Blackrock 13M $2.14B -0.7%
STT State Street 7.31M $1.21B +3.1%
APG Asset Management US 6.11M $1B +10.3%
PFG Principal Financial Group Inc - Registered Shares 4.96M $814.18M +2.6%
PGGM Investments 3.86M $633.76M +67.3%
JPM JPMorgan Chase & Co. 3.75M $616.04M +59.2%
Capital World Investors 3.42M $562.02M +0.0%
Capital Research Global Investors 2.76M $453.85M +3.1%
Geode Capital Management 2.46M $403.81M +2.9%
Largest transactions
Shares Bought/sold Change
Norges Bank 0 -11.66M EXIT
Parnassus Investments 1.65M +1.65M NEW
PGGM Investments 3.86M +1.55M +67.3%
JPM JPMorgan Chase & Co. 3.75M +1.39M +59.2%
Wellington Management 1.63M -979.34K -37.6%
Vanguard 21.15M +880.81K +4.3%
IVZ Invesco 1.5M -833.38K -35.8%
DB Deutsche Bank AG - Registered Shares 391.46K -697.38K -64.0%
AMP Ameriprise Financial 394.74K -609.96K -60.7%
APG Asset Management US 6.11M +573K +10.3%

Financial report summary

?
Management Discussion
  • We present a tabular comparison of items, whether gain or loss, that may facilitate a high-level understanding of our results and provide context for the disclosures included in our annual report on Form 10-K for the year ended December 31, 2020, and our subsequent quarterly reports on Form 10-Q. We believe such tabular presentation promotes a better understanding for investors of the corporate-level decisions made and activities performed that significantly affect comparison of our operating results from period to period. We also believe this tabular presentation will supplement for investors an understanding of our disclosures and real estate operating results. Gains or losses on sales of real estate and impairments of held for sale assets are related to corporate-level decisions to dispose of real estate. Gains or losses on early extinguishment of debt are related to corporate-level financing decisions focused on our capital structure strategy. Significant realized and unrealized gains or losses on non-real estate investments, impairments of real estate and non-real estate investments, and significant termination fees are not related to the operating performance of our real estate assets as they result from strategic, corporate-level decisions and external market conditions. Impairments of non-real estate investments are not related to the operating performance of our real estate as they represent the write-down of non-real estate investments when their fair values decline below their respective carrying values due to changes in general market or other conditions outside of our control. Significant items, whether a gain or loss, included in the tabular disclosure for current periods are described in further detail within this Item 2. Key items included in net income attributable to Alexandria’s common stockholders for the three and six months ended June 30, 2021 and 2020, were as follows (in millions, except per share amounts):
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: absolute, accommodate, advantage, agenda, alert, alteration, attack, attention, breach, bullet, carbon, catastrophic, cloud, Commission, commodity, compounded, concrete, confidential, conveyed, coordination, copper, costlier, credential, cybersecurity, damage, denial, destruction, destructive, detect, detected, devoted, Dexter, differentiated, electrical, electronic, elevate, encounter, encountered, ESG, EU, European, evidence, exert, exfiltration, Finally, flagship, fraudulently, frequency, fueled, garage, guessing, hiring, HVAC, illegal, inadequate, incident, induce, inflation, inflationary, inoculate, intelligence, intensified, intrusion, letter, litigation, loading, lucrative, lumber, manipulated, massive, mega, merit, misappropriation, misuse, nearest, outgoing, oversupply, Pension, planted, plumbing, plywood, preacquisition, premier, pressure, proliferation, properly, proprietary, qualification, Ranch, raw, receipt, regularly, Reinforced, rely, repeated, reportedly, reserve, reset, resetting, roster, rulemaking, Russian, safeguard, seat, sending, Sequence, setup, short, software, sophisticated, sophistication, sovereign, spamming, spoofed, spoofing, steel, stipulate, storage, stricter, suitable, supplier, suspended, theft, tightening, transmission, unanticipated, unauthorized, underestimate, unhedged, unvaccinated, upgraded, valuable, vendor, verification, Violation, voluntary, wealth
Removed: AbbVie, academic, accelerate, achieving, addiction, advancing, AG, aid, amenity, Amgen, antibody, antiviral, approved, assistance, AstraZeneca, asymptomatic, Atreca, backdrop, breath, career, Carolina, Centre, chairman, challenge, children, clarity, classifying, clinic, Color, commenced, commercialization, conference, confirm, convenience, convention, convert, cough, Dayton, death, decreased, dedicated, diminishing, discovery, distressed, donated, dosage, dual, ecosystem, education, educational, efficacy, elderly, Eli, enabled, endeavoring, entertainment, entrance, epidemic, expedite, experimental, expertise, expired, facing, family, fatigue, fever, financed, Fisher, foundation, founder, fragment, fundamental, gap, Gilead, GlaxoSmithKline, goal, grocery, hardship, healthcare, healthy, heroic, highlighting, holistic, hope, housing, illustrative, IMF, immune, inactivated, infected, infection, inspiring, investigational, job, Joel, laying, Lilly, live, living, lockdown, Los, maintaining, mandatory, manufacturing, meaningful, Merck, mild, mission, moderate, movement, movie, myriad, neighboring, nonessential, noted, Novavax, November, Ohio, OneFifteen, open, opioid, overdose, package, Paycheck, placebo, placement, plc, pneumonia, preclinical, President, principle, productive, profound, protein, provoke, Quest, rapidly, receiving, regional, remdesivir, repurpose, rescinded, residential, rest, reunification, reverse, role, Sanofi, scalable, school, scientific, September, serve, served, serving, shutdown, shutting, span, speed, split, sponsored, spread, STEM, studied, subpopulation, subset, sustained, taste, test, therapeutic, therapy, Thermo, Towne, tracking, training, treated, trial, turnaround, underserved, urgent, vector, Verily, version, vir, Viral, virtually, Warp, Washington, weakened, widespread, worldwide, worship